4.5 Article

Strategic multimodal non-invasive assessment of cardiac performance in patients with heart failure

Journal

ESC HEART FAILURE
Volume 10, Issue 4, Pages 2567-2576

Publisher

WILEY PERIODICALS, INC
DOI: 10.1002/ehf2.14425

Keywords

Brain natriuretic peptide; Echocardiography; Exercise test; Heart failure; Prognosis

Ask authors/readers for more resources

This study aims to predict long-term outcomes of heart failure patients by combining various non-invasive cardiac examinations. The results showed that the combination of plasma NT-proBNP level and echocardiographic findings (Echo-LVFP) could stratify patients into three groups and predict adverse outcomes. Left atrial mechanics and exercise capacity further improved the accuracy of prognosis.
AimsAlthough various non-invasive cardiac examinations are known to be predictive of long-term outcomes in patients with heart failure (HF), combining them properly would provide synergism. We aimed to show that non-invasive cardiac assessments targeting left ventricular filling pressure (LVFP), left atrial remodelling, and exercise capacity would provide better prognostication in combination. Methods and resultsThis prospective observational study included consecutive hospitalized stage A-C HF patients evaluated with N-terminal pro-B-type natriuretic peptide (NT-proBNP), echocardiography including two-dimensional speckle tracking, and cardiopulmonary exercise testing. According to NT-proBNP and echocardiographic semi-quantitative LVFP grading (Echo-LVFP), patients were classified into three LVFP groups: normal range of both Echo-LVFP and NT-proBNP (Group 1), normal range of Echo-LVFP but elevated NT-proBNP (Group 2), and elevated Echo-LVFP and NT-proBNP (Group 3). The adverse outcome was defined as a composite of cardiovascular death, non-fatal acute coronary syndrome, acute stroke, or HF-related hospitalization. Among 224 HF patients (mean age of 63.8 +/- 11.6 years, 158 men) analysed, 160 (71.4%) had ischaemic aetiology. During the follow-up of 18.6 +/- 9.8 months, event-free survival in Group 2 (n = 56, age of 65.4 +/- 12.4) was better than that in Group 3 (n = 45, age of 68.5 +/- 11.5) but worse than that in Group 1 (n = 123, mean age of 61.4 +/- 10.5) (log-rank P < 0.001). Mechanical left atrial dysfunction (peak longitudinal strain <28%) (adjusted hazard ratio 5.69, 95% confidence interval 1.06-4.48) and limited exercise capacity (peak VO2 per +5 mL/kg/min) (adjusted hazard ratio 0.63, 95% confidence interval 0.46-0.87) were also predictable adverse outcomes. Serial addition of peak VO2 and left atrial strain to the model incrementally enhanced the predictive power of LVFP-based risk stratification for adverse outcomes. ConclusionsThe combination of NT-proBNP and Echo-LVFP could be used to predict adverse outcomes in patients with HF of various stages. Left atrial mechanics and exercise capacity are incremental to prognostication. Non-invasive test findings could be strategically combined to provide an integrative profile of cardiac performance.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available